{"entity":{"type":"insider","cik":"0001378166","url":"/insider/0001378166","json_url":"/insider/0001378166.json","name":"Young David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":24,"first":"2010-11-04","last":"2026-07-01","span_basis":"filed_date"},"name_variants":[{"name":"Young David","source":"filing","n_filings":24,"first_seen":"2010-11-04","last_seen":"2026-07-01"}],"transactions":[{"id":5761054,"accession":"0000897069-26-001476","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001476","line_url":"/filing/0000897069-26-001476#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (Pres. Research & Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. Research & Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2531.0,"shares_display":"2,531","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":4884.83,"total_display":"4,884.83","total_whole":"4,885","shares_owned_after":21729.0,"shares_owned_after_display":"21,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-01","scope":"insider"},{"id":5936929,"accession":"0000897069-26-001414","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001414","line_url":"/filing/0000897069-26-001414#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (Pres. Research & Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. Research & Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2067.0,"shares_display":"2,067","price_per_share":2.22,"price_display":"2.22","price_state":"stated","total_value":4588.74,"total_display":"4,588.74","total_whole":"4,589","shares_owned_after":19198.0,"shares_owned_after_display":"19,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-16","scope":"insider"},{"id":5804815,"accession":"0000897069-26-001295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001295","line_url":"/filing/0000897069-26-001295#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (Pres. Research & Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. Research & Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1786.0,"shares_display":"1,786","price_per_share":2.57,"price_display":"2.57","price_state":"stated","total_value":4590.02,"total_display":"4,590.02","total_whole":"4,590","shares_owned_after":17131.0,"shares_owned_after_display":"17,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-29","filed_date":"2026-06-01","scope":"insider"},{"id":6145790,"accession":"0000897069-26-001184","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001184","line_url":"/filing/0000897069-26-001184#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (Pres. Research & Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. Research & Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1545.0,"shares_display":"1,545","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":4588.65,"total_display":"4,588.65","total_whole":"4,589","shares_owned_after":15345.0,"shares_owned_after_display":"15,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-19","scope":"insider"},{"id":5832035,"accession":"0000897069-26-001010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001010","line_url":"/filing/0000897069-26-001010#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (Pres. Research & Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. Research & Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1706.0,"shares_display":"1,706","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":4589.14,"total_display":"4,589.14","total_whole":"4,589","shares_owned_after":13813.0,"shares_owned_after_display":"13,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-05-01","scope":"insider"},{"id":5761050,"accession":"0000897069-26-000912","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-000912","line_url":"/filing/0000897069-26-000912#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (Pres. Research & Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. Research & Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1545.0,"shares_display":"1,545","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":4588.65,"total_display":"4,588.65","total_whole":"4,589","shares_owned_after":12107.0,"shares_owned_after_display":"12,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-17","scope":"insider"},{"id":5804801,"accession":"0000897069-26-000756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-000756","line_url":"/filing/0000897069-26-000756#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (Pres. Research & Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. Research & Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1810.0,"shares_display":"1,810","price_per_share":2.535,"price_display":"2.54","price_state":"stated","total_value":4588.35,"total_display":"4,588.35","total_whole":"4,588","shares_owned_after":10562.0,"shares_owned_after_display":"10,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-01","scope":"insider"},{"id":4261393,"accession":"0000897069-25-000132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-25-000132","line_url":"/filing/0000897069-25-000132#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (Pres. Research & Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. Research & Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":124500.0,"shares_display":"124,500","price_per_share":0.7975,"price_display":"0.80","price_state":"stated","total_value":99288.75,"total_display":"99,288.75","total_whole":"99,289","shares_owned_after":205405.0,"shares_owned_after_display":"205,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-27","filed_date":"2025-01-29","scope":"insider"},{"id":2621401,"accession":"0000897069-24-000269","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-24-000269","line_url":"/filing/0000897069-24-000269#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (Pres. Research & Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. Research & Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21000.0,"shares_display":"21,000","price_per_share":2.4536,"price_display":"2.45","price_state":"stated","total_value":51525.6,"total_display":"51,525.60","total_whole":"51,526","shares_owned_after":79387.0,"shares_owned_after_display":"79,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-07","filed_date":"2024-02-08","scope":"insider"},{"id":3067065,"accession":"0000897069-24-000253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-24-000253","line_url":"/filing/0000897069-24-000253#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (Pres. Research & Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. Research & Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.5252,"price_display":"2.53","price_state":"stated","total_value":50504.0,"total_display":"50,504.00","total_whole":"50,504","shares_owned_after":58387.0,"shares_owned_after_display":"58,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-07","scope":"insider"},{"id":7986989,"accession":"0000897069-23-000716","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-23-000716","line_url":"/filing/0000897069-23-000716#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":32000.0,"total_display":"32,000.00","total_whole":"32,000","shares_owned_after":470424.0,"shares_owned_after_display":"470,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-12","scope":"insider"},{"id":8061887,"accession":"0000897069-23-000278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-23-000278","line_url":"/filing/0000897069-23-000278#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.5499,"price_display":"0.55","price_state":"stated","total_value":10998.0,"total_display":"10,998.00","total_whole":"10,998","shares_owned_after":430424.0,"shares_owned_after_display":"430,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-14","filed_date":"2023-04-14","scope":"insider"},{"id":8184864,"accession":"0000897069-23-000269","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000897069-23-000269","line_url":"/filing/0000897069-23-000269#line-3","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.48,"price_display":"0.48","price_state":"stated","total_value":9600.0,"total_display":"9,600.00","total_whole":"9,600","shares_owned_after":410424.0,"shares_owned_after_display":"410,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-13","filed_date":"2023-04-13","scope":"insider"},{"id":8184857,"accession":"0000897069-23-000269","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000897069-23-000269","line_url":"/filing/0000897069-23-000269#line-2","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","total_whole":"9,000","shares_owned_after":390424.0,"shares_owned_after_display":"390,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-12","filed_date":"2023-04-13","scope":"insider"},{"id":8184851,"accession":"0000897069-23-000269","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-23-000269","line_url":"/filing/0000897069-23-000269#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.52,"price_display":"0.52","price_state":"stated","total_value":10400.0,"total_display":"10,400.00","total_whole":"10,400","shares_owned_after":370424.0,"shares_owned_after_display":"370,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-11","filed_date":"2023-04-13","scope":"insider"},{"id":5377026,"accession":"0001567619-21-012540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-012540","line_url":"/filing/0001567619-21-012540#line-1","is_derivative":false,"issuer_cik":"0001378166","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001378166","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.6716,"price_display":"7.67","price_state":"stated","total_value":76716.0,"total_display":"76,716.00","total_whole":"76,716","shares_owned_after":345190.0,"shares_owned_after_display":"345,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-23","filed_date":"2021-06-23","scope":"insider"},{"id":6295507,"accession":"0001209191-14-043947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-043947","line_url":"/filing/0001209191-14-043947#line-2","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":91.9606,"price_display":"91.96","price_state":"stated","total_value":551763.6,"total_display":"551,763.60","total_whole":"551,764","shares_owned_after":117741.0,"shares_owned_after_display":"117,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-24","filed_date":"2014-06-26","scope":"insider"},{"id":6947215,"accession":"0001209191-14-021388","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-021388","line_url":"/filing/0001209191-14-021388","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":62.27813175,"price_display":"62.28","price_state":"stated","total_value":373668.7905,"total_display":"373,668.79","total_whole":"373,669","shares_owned_after":111741.0,"shares_owned_after_display":"111,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-14","filed_date":"2014-03-18","scope":"insider","n_lines":2},{"id":6293454,"accession":"0001209191-14-014626","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-014626","line_url":"/filing/0001209191-14-014626#line-6","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":78.8816,"price_display":"78.88","price_state":"stated","total_value":473289.6,"total_display":"473,289.60","total_whole":"473,290","shares_owned_after":105351.0,"shares_owned_after_display":"105,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-24","filed_date":"2014-02-26","scope":"insider"},{"id":6259099,"accession":"0001209191-14-005392","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-005392","line_url":"/filing/0001209191-14-005392#line-2","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":64.3824,"price_display":"64.38","price_state":"stated","total_value":386294.4,"total_display":"386,294.40","total_whole":"386,294","shares_owned_after":91145.0,"shares_owned_after_display":"91,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-24","filed_date":"2014-01-28","scope":"insider"},{"id":4451837,"accession":"0001181431-13-059307","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-059307","line_url":"/filing/0001181431-13-059307#line-2","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":62.4003,"price_display":"62.40","price_state":"stated","total_value":6240030.0,"total_display":"6,240,030.00","total_whole":"6,240,030","shares_owned_after":74603.0,"shares_owned_after_display":"74,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-13","filed_date":"2013-11-15","scope":"insider"},{"id":3125221,"accession":"0001181431-12-026773","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-026773","line_url":"/filing/0001181431-12-026773#line-2","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":42.81,"price_display":"42.81","price_state":"stated","total_value":2996700.0,"total_display":"2,996,700.00","total_whole":"2,996,700","shares_owned_after":3278.0,"shares_owned_after_display":"3,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-27","filed_date":"2012-05-01","scope":"insider"},{"id":9044513,"accession":"0001181431-11-054340","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-054340","line_url":"/filing/0001181431-11-054340","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79724.0,"shares_display":"79,724","price_per_share":41.05192413827706,"price_display":"41.05","price_state":"stated","total_value":3272823.6,"total_display":"3,272,823.60","total_whole":"3,272,824","shares_owned_after":8002.0,"shares_owned_after_display":"8,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-31","filed_date":"2011-11-02","scope":"insider","n_lines":2},{"id":9188274,"accession":"0001181431-11-045794","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-11-045794","line_url":"/filing/0001181431-11-045794","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6092.0,"shares_display":"6,092","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":194944.0,"total_display":"194,944.00","total_whole":"194,944","shares_owned_after":8302.0,"shares_owned_after_display":"8,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-15","filed_date":"2011-08-16","scope":"insider","n_lines":2},{"id":9188271,"accession":"0001181431-11-045794","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-045794","line_url":"/filing/0001181431-11-045794","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9308.0,"shares_display":"9,308","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":297856.0,"total_display":"297,856.00","total_whole":"297,856","shares_owned_after":8402.0,"shares_owned_after_display":"8,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-12","filed_date":"2011-08-16","scope":"insider","n_lines":2},{"id":8880877,"accession":"0001181431-11-044661","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-044661","line_url":"/filing/0001181431-11-044661#line-2","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.5,"price_display":"28.50","price_state":"stated","total_value":285000.0,"total_display":"285,000.00","total_whole":"285,000","shares_owned_after":8402.0,"shares_owned_after_display":"8,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-05","filed_date":"2011-08-09","scope":"insider"},{"id":7667611,"accession":"0001181431-10-053620","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-053620","line_url":"/filing/0001181431-10-053620#line-4","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":"0001378166","owner_name":"Young David","owner_display_name":"Young David","owner_url":"/insider/0001378166","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28125.0,"shares_display":"28,125","price_per_share":12.3339,"price_display":"12.33","price_state":"stated","total_value":346890.9375,"total_display":"346,890.94","total_whole":"346,891","shares_owned_after":8297.0,"shares_owned_after_display":"8,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-02","filed_date":"2010-11-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001533743","name":"Processa Pharmaceuticals, Inc.","url":"/issuer/0001533743","role":"Director, Officer (Pres. Research & Development), Ten percent owner","n_filings":14,"first_seen":"2021-06-23","last_seen":"2026-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0000891288","name":"QUESTCOR PHARMACEUTICALS INC","url":"/issuer/0000891288","role":"Officer (Chief Scientific Officer)","n_filings":10,"first_seen":"2010-11-04","last_seen":"2014-06-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001378166","retrieved_at":"2026-08-23T00:41:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}